INX-315
Product Specifications
CAS Number
2745060-92-6
Target
CDK, Early 2 Factor (E2F)
Related Pathways
Cell Cycle/Checkpoint
Purity
0.9988
Bioactivity
INX-315 is an orally active, selective CDK2 inhibitor that induces cell cycle arrest and senescence in solid tumours, suppresses E2F target gene expression, and exhibits anticancer activity in ccne1-amplified cancers and cdk4/6i-resistant intraductal breast cancer models.
Smiles
O=C1NNC2=CC=3C=NC(=NC3N2C14CCCCC4)NC5=CC=C(C=C5)S(=O)(=O)N
Molecular Formula
C19H21N7O3S
Molecular Weight
427.48
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
VD11Y610 1 Each
Rabbit Anti-Trypanosoma cruzi Heat Shock Protein 100 Polyclonal Antibody
Sign In for Pricing
View Details 
I7663-97H-APC 100 µL
Interleukin 33 (IL-33, C9orf26, DKFZp586H0523, DVS27, IL1F11, IL-1F11, Interleukin-1 Family Member 11, Interleukin-33, NFEHEV, NFHEV, NF-HEV, Nuclear Factor from High Endothelial Venules, RP11-575C20.2) (APC)
Sign In for Pricing
View Details MBS8119705-01 0.3 mg
SARS-CoV-2 (2019-nCoV) Spike RBD(T393P)-His Recombinant HEK293 Cell Lysate (WB positive control)
Sign In for Pricing
View Details MBS8119705-02 5x 0.3 mg
SARS-CoV-2 (2019-nCoV) Spike RBD(T393P)-His Recombinant HEK293 Cell Lysate (WB positive control)
Sign In for Pricing
View Details